Cytokine-mediated tissue regeneration

Cytokine-mediated tissue regeneration refers to the collective process whereby cytokines—small secreted proteins produced by immune and resident tissue cells—modulate the immune microenvironment, orchestrating the healing cascade following tissue injury. This process involves a coordinated sequence of events beginning with inflammation, driven by pro-inflammatory cytokines (e.g., TNFα, IL-1β, IL-6), followed by anti-inflammatory and regenerative cytokines (e.g., IL-4, IL-13, TGF-β) that resolve inflammation, activate local progenitor cell populations, and support regrowth and remodeling of tissue. Dysregulation can result in pathological outcomes such as chronic inflammation or fibrosis. Cytokine-targeted therapies aim to fine-tune this balance to promote effective tissue repair while minimizing adverse sequelae[1][2][4][6][7].

Other names

Cytokine-driven tissue regenerationCytokine-regulated tissue regenerationCytokine-dependent tissue regeneration

Drugs modulate the activity of specific cytokines or their receptors to influence inflammation or tissue repair phases[3][4][6]. Examples include inhibition of pro-inflammatory cytokines to reduce fibrosis, or administration of growth factors to enhance regeneration.